Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
114.00    2.50 (2.24%)
Bid:
112.00
Ask:
116.00
Spread: 4.00 (3.571%)
Market Cap: £68.59m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Share Buyback Programme

25 Oct 2024 07:00

RNS Number : 5356J
Intercede Group PLC
25 October 2024
 

 

 

25 October 2024

 

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Share Buyback Programme

Intercede, the leading cybersecurity software company specialising in digital identities, today announces the launch of a share buyback programme to acquire ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") up to the gross value of £1,000,000 (the "Programme" or the "Buyback").

With the current uncertainty in the AIM market regarding HM's Government Autumn Budget on 30 October 2024, relating to potential changes to Inheritance Tax legislation, the possible removal of Business Property Relief for qualifying companies quoted on AIM and the resultant Company's share price volatility, the Board have decided to commence a Buyback programme.

The Board takes a disciplined approach to investment, returns and the capital efficiency of the Group to maximise shareholder value with a focus on the continued execution of its strategy, combining organic growth with the potential to complement this growth with M&A. Furthermore, the Board believes that the Group's strong balance sheet and cash generation provides the opportunity to take advantage of current market conditions to repurchase shares to hold in treasury for the purpose of satisfying future obligations in relation to its employees' or other share schemes and improve shareholder returns.

The Buyback is in accordance with the terms of the Company's authority to make market purchases of its own ordinary shares of 1 pence each in the capital of the Company granted to it by shareholders on 25 September 2024 (the "Authority"), including that the maximum price paid per Ordinary Share is to be no more than 105 percent. of the average middle market closing price of an Ordinary Share for the five business days preceding the date of any purchase.

The Buyback commences today and will then end on 31 December 2024 (subject to earlier termination in the event the full £1,000,000 is expended). The Company has instructed Cavendish Capital Markets Limited ("Cavendish") to act as sole administrator to execute and manage the Buyback on its behalf and has given irrevocable instructions to Cavendish to make market purchases of Ordinary Shares on its behalf, independently of the Company. Cavendish will make trading decisions in relation to the Ordinary Shares independently of and uninfluenced by the Company with such trading decisions being in line with the terms of the Buyback.

 

Shareholders should be aware that the Buyback will, insofar as is possible, be conducted in accordance with the safe harbour parameters of MAR (as defined below); however, the Buyback may on any given trading day represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and could exceed 25 per cent of the average daily trading volume. Accordingly, the Company may not benefit from the exemption contained in Article 5(1) in the UK version of the Market Abuse Regulations (Regulation (EU) No 596/2014) as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

Any market purchase of Ordinary Shares pursuant to the Buyback will be announced no later than 7.30am on the business day following the day on which the purchase occurred.

 

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

Cavendish Capital Markets Limited (Nomad & Broker)

Tel. + 44 (0)20 7220 0500

Marc Milmo/Fergus Sullivan/Rory Sale

Corporate Finance

Tim Redfern/Ondraya Swanson

Corporate Broking

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

 

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO, and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and custom development capabilities as well as managing the world's largest password breach database.

 

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

For more information visit: www.intercede.com

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFEEISLSFIS
Date   Source Headline
6th Nov 20147:00 amRNSShare Buyback Programme
6th Nov 20147:00 amRNSHalf Yearly Report
7th Oct 20147:00 amRNSTrading Update
29th Sep 20147:00 amRNSFirst Customer: Derived Credentials for Mobile
17th Sep 20144:25 pmRNSResult of AGM
1st Aug 20147:00 amRNSShare Incentive Plan
26th Jun 20149:37 amRNSDirector/PDMR Shareholding
25th Jun 20141:20 pmRNSDirector Share Dealings
10th Jun 20147:00 amRNSDirector Share Dealings
5th Jun 20147:00 amRNSFinal Results
6th May 201410:32 amRNSShare Incentive Plan
1st Apr 20147:00 amRNSDirectorate Change
27th Mar 20147:00 amRNSTransaction in Own Shares
25th Mar 201410:35 amRNSTransfer of Treasury Shares
20th Mar 20147:00 amRNSTransaction in Own Shares
13th Mar 20147:00 amRNSShare Incentive Plan
13th Mar 20147:00 amRNSTransfer of Treasury Shares
4th Mar 20149:09 amRNSTransaction in Own Shares
27th Feb 20147:00 amRNSTransaction in Own Shares
13th Feb 20147:00 amRNSTransaction in Own Shares
7th Feb 20147:00 amRNSPartnership with TELUS and Gemalto
5th Feb 20147:00 amRNSTransaction in Own Shares
28th Jan 201411:30 amRNSTransaction in Own Shares
13th Jan 20147:00 amRNSShare Buyback Programme
8th Jan 20147:00 amRNSTrading Update
10th Dec 20136:00 pmRNSDirector Share Dealings
10th Dec 20134:49 pmRNSDirector Share Dealings
21st Nov 20137:00 amRNSHalf Yearly Report
5th Nov 20137:00 amRNSNew Contract Win
1st Oct 20137:00 amRNSDirector Share Dealings
26th Sep 20137:00 amRNSDirector/PDMR Shareholding
25th Sep 20131:00 pmRNSResult of AGM
25th Sep 20137:00 amRNSContract Wins and AGM Statement
9th Sep 20137:00 amRNSDirectors' Holding
29th Jul 20137:00 amRNSContract awards and Trading update
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
4th Jun 20137:00 amRNSFinal Results
25th Apr 20137:00 amRNSContract Win
16th Apr 20137:00 amRNSAppointment of Non-Executive Director
5th Apr 20137:00 amRNSYear end trading update
1st Feb 20137:00 amRNSTrading Update
3rd Dec 20127:00 amRNSHolding(s) in Company
22nd Nov 20127:00 amRNSInterim Results
4th Oct 20127:00 amRNSTrading Update
26th Sep 20124:39 pmRNSResult of AGM
21st Aug 20127:00 amRNSAmendments to LTIP
4th Jul 20123:35 pmRNSDirector/PDMR Shareholding
14th Jun 20122:37 pmRNSIssue of Equity
12th Jun 201210:13 amRNSDirector/PDMR Shareholding and Issue of equity
5th Apr 20127:00 amRNSYear End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.